Toggle Main Menu Toggle Search

Open Access padlockePrints

Browsing publications by Dr Ilse Pienaar.

Newcastle AuthorsTitleYearFull text
Dr Joanna Elson
Dr Ilse Pienaar
A Novel Mitochondria-Targeting Iron Chelator Neuroprotects Multimodally via HIF-1 Modulation Against a Mitochondrial Toxin in a Dopaminergic Cell Model of Parkinson’s Disease2023
Dr Hilmar Sigurdsson
Heather Hunter
Dr Lisa Alcock
Ross Wilson
Dr Ilse Pienaar
et al.
Safety and tolerability of adjunct non-invasive vagus nerve stimulation in people with parkinson's: a study protocol2023
Dr Jannetta Steyn
Dr Ilse Pienaar
Dr Joanna Elson
Mitochondrial DNA population variation is not associated with Alzheimer's in the Japanese population: A consistent finding across global populations2022
Dr Ilse Pienaar
Dr Joanna Elson
Investigation of the Correlation Between Mildly Deleterious mtDNA Variations and the Clinical Progression of Multiple Sclerosis2021
Dr Joanna Elson
Dr Ilse Pienaar
Design and evaluation of bi-functional iron chelators for protection of dopaminergic neurons from toxicants2020
Dr Joanna Elson
Dr Meera Soundararajan
Dr Ilse Pienaar
Novel 1-hydroxypyridin-2-one metal chelators prevent and rescue ubiquitin proteasomal-related neuronal injury in an in vitro model of Parkinson’s disease2020
Dr Cara Tomas
Dr Ilse Pienaar
Vicki Strassheim
Professor Fai Ng
Emerita Professor Julia Newton
et al.
MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants2019
Rebecca Brennan
Dr Ilse Pienaar
Professor Francois van der Westhuizen
Dr Joanna Elson
The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects2019
Dr Joanna Elson
Dr Ilse Pienaar
Temporal-Spatial Profiling of Pedunculopontine Galanin-Cholinergic Neurons in the Lactacystin Rat Model of Parkinson’s Disease2018
Dr Ilse Pienaar
Dr Joanna Elson
Mildly deleterious mitochondrial DNA variants are less frequent in healthy older individuals, but not more prevalent in Alzheimer’s patients2017
Alex Bury
Dr Angela Pyle
Dr Joanna Elson
Professor Laura Greaves
Dr Christopher Morris
et al.
Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease2017
Dr Ilse Pienaar
Dr Joanna Elson
MutPred mutational load analysis shows mildly deleterious mitochondrial DNA variants are not more prevalent in Alzheimer's patients, but may be under-represented in healthy older individuals2017
Dr Ilse Pienaar
Dr Joanna Elson
Alex Bury
An animal model mimicking pedunculopontine nucleus cholinergic degeneration in Parkinson's disease2015
Dr Ilse Pienaar
Dr Joanna Elson
Professor Raj Kalaria
Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease2015
Dr Ilse Pienaar
Dr Sasha Gartside
Sabine Gretenkord
Dr Joanna Elson
Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's disease2015
Dr Ilse Pienaar
Professor Patrick Chinnery
Existing and emerging mitochondrial-targeting therapies for altering Parkinson's disease severity and progression2013
Dr Ilse Pienaar
Dr Joanna Elson
Dr Claudia Racca
Dr Glyn Nelson
Emeritus Professor Doug Turnbull
et al.
Mitochondrial Abnormality Associates with Type-Specific Neuronal Loss and Cell Morphology Changes in the Pedunculopontine Nucleus in Parkinson Disease2013
Dr Carole Proctor
Dr Ilse Pienaar
Dr Joanna Elson
Emeritus Professor Thomas Kirkwood
Aggregation, impaired degradation and immunization targeting of amyloid-beta dimers in Alzheimer's disease: A stochastic modelling approach2012
Dr Nichola Lax
Dr Ilse Pienaar
Dr Amy Reeve
Philippa Hepplewhite
Dr Evelyn Jaros
et al.
Microangiopathy in the cerebellum of patients with mitochondrial DNA disease2012